Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanism

被引:23
|
作者
Bash-Imam, Zeina [1 ]
Therizols, Gabriel [1 ]
Vincent, Anne [1 ]
Laforets, Florian [1 ]
Espinoza, Micaela Polay [1 ]
Pion, Nathalie [1 ]
Macari, Francoise [4 ]
Pannequin, Julie [4 ]
David, Alexandre [4 ]
Saurin, Jean-Christophe [1 ]
Mertani, Hichem C. [1 ]
Textoris, Julien [3 ]
Auboeuf, Didier [1 ]
Catez, Frederic [1 ]
Venezia, Nicole Dalla [1 ]
Dutertre, Martin [2 ]
Marcel, Virginie [1 ]
Diaz, Jean-Jacques [1 ]
机构
[1] Univ Lyon 1, INSERM 1052, CNRS 5286, Ctr Leon Berard,Ctr Rech Cancerol Lyon, F-69373 Lyon, France
[2] Ctr Univ Orsay, CNRS UMR 3348, Inst Curie, F-91405 Orsay, France
[3] Univ Lyon 1, Hosp Civils Lyon, bioMerieux SA Pathophysiol Injury Induced Immunos, EA7426, F-69003 Lyon, France
[4] Univ Montpellier, INSERM, CNRS, IGF, F-34094 Montpellier, France
关键词
5-fluorouracil; translation; translatome profiling; miRNA; colorectal cancer; RNA METHYLATION; GENE; IDENTIFICATION; CYTOTOXICITY; FLUOROURACIL; INHIBITION; APOPTOSIS; TARGETS; DNA;
D O I
10.18632/oncotarget.17597
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5-fluorouracil (5-FU) is a widely used chemotherapeutic drug in colorectal cancer. Previous studies showed that 5-FU modulates RNA metabolism and mRNA expression. In addition, it has been reported that 5-FU incorporates into the RNAs constituting the translational machinery and that 5-FU affects the amount of some mRNAs associated with ribosomes. However, the impact of 5-FU on translational regulation remains unclear. Using translatome profiling, we report that a clinically relevant dose of 5-FU induces a translational reprogramming in colorectal cancer cell lines. Comparison of mRNA distribution between polysomal and non-polysomal fractions in response to 5-FU treatment using microarray quantification identified 313 genes whose translation was selectively regulated. These regulations were mostly stimulatory (91%). Among these genes, we showed that 5-FU increases the mRNA translation of HIVEP2, which encodes a transcription factor whose translation in normal condition is known to be inhibited by mir-155. In response to 5-FU, the expression of mir-155 decreases thus stimulating the translation of HIVEP2 mRNA. Interestingly, the 5-FU-induced increase in specific mRNA translation was associated with reduction of global protein synthesis. Altogether, these findings indicate that 5-FU promotes a translational reprogramming leading to the increased translation of a subset of mRNAs that involves at least for some of them, miRNA-dependent mechanisms. This study supports a still poorly evaluated role of translational control in drug response.
引用
收藏
页码:46219 / 46233
页数:15
相关论文
共 50 条
  • [31] Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil
    Gabriella Calviello
    Fiorella Di Nicuolo
    Simona Serini
    Elisabetta Piccioni
    Alma Boninsegna
    Nicola Maggiano
    Franco O. Ranelletti
    Paola Palozza
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 12 - 20
  • [32] Inhibition of GOT1 sensitizes colorectal cancer cells to 5-fluorouracil
    Chengyu Hong
    Jian Zheng
    Xiaoling Li
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 835 - 840
  • [33] Beyond 5-fluorouracil monochemotherapy in colorectal cancer - It is time
    Satta, F
    Franchi, F
    JOURNAL OF CHEMOTHERAPY, 1997, 9 (06) : 431 - 435
  • [34] Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer
    Fioravanti, Anna
    Canu, Bastianina
    Ali, Greta
    Orlandi, Paola
    Allegrini, Giacomo
    Di Desidero, Teresa
    Emrilenegger, Urban
    Fontanini, Gabriella
    Danesi, Romano
    Del Tacca, Mario
    Falcone, Alfredo
    Bocci, Guido
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 619 (1-3) : 8 - 14
  • [35] Upregulation of enzymes metabolizing 5-fluorouracil in colorectal cancer
    Matsusaka, Satoshi
    Yamasaki, Hajime
    Fukushima, Masakazu
    Wakabayashi, Ichiro
    CHEMOTHERAPY, 2007, 53 (01) : 36 - 41
  • [36] Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
    Xie, Pan
    Mo, Jun-Luan
    Liu, Jin-Hong
    Li, Xi
    Tan, Li-Ming
    Zhang, Wei
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    CELLULAR ONCOLOGY, 2020, 43 (06) : 989 - 1001
  • [37] Pathways of oxaliplatin/5-fluorouracil resistance in colorectal cancer
    Turkington, R.
    Allen, W.
    Stevenson, L.
    Coyle, V.
    Jithesh, P.
    Proutski, I.
    Fenning, C.
    Stewart, G.
    Longley, D.
    Johnston, P.
    EJC SUPPLEMENTS, 2009, 7 (02): : 342 - 342
  • [38] 5-Fluorouracil in colorectal cancer, a never ending story
    Herrmann, R
    ANNALS OF ONCOLOGY, 1996, 7 (06) : 551 - 552
  • [39] Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
    Pan Xie
    Jun-Luan Mo
    Jin-Hong Liu
    Xi Li
    Li-Ming Tan
    Wei Zhang
    Hong-Hao Zhou
    Zhao-Qian Liu
    Cellular Oncology, 2020, 43 : 989 - 1001
  • [40] 5-FLUOROURACIL MODULATION IN THE CHEMOTHERAPY OF COLORECTAL-CANCER
    CODACCIPISANELLI, G
    FRANCHI, F
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1994, 26 (07): : 369 - 376